Prevalence of prediabetes and type 2 diabetes mellitus in south and southeast Asian women with history of gestational diabetes mellitus: Systematic review and meta-analysis. 2022

Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
Division of Populations, Evidence, and Technologies of Health Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom.

The burden of Gestational Diabetes Mellitus (GDM) is very high in south Asia (SA) and southeast Asia (SEA). Thus, there is a need to understand the prevalence and risk factors for developing prediabetes and type 2 diabetes mellitus (T2DM) postpartum, in this high-risk population. To conduct a systematic review and meta-analysis to estimate the prevalence of prediabetes and T2DM among the women with history of GDM in SA and SEA. A comprehensive literature search was performed in the following databases: Medline, EMBASE, Web of Knowledge and CINHAL till December 2021. Studies that had reported greater than six weeks of postpartum follow-up were included. The pooled prevalence of diabetes and prediabetes were estimated by random effects meta-analysis model and I2 statistic was used to assess heterogeneity. Meta-analysis of 13 studies revealed that the prevalence of prediabetes and T2DM in post-GDM women were 25.9% (95%CI 18.94 to 33.51) and 29.9% (95%CI 17.02 to 44.57) respectively. Women with history of GDM from SA and SEA seem to have higher risk of developing T2DM than women without GDM (RR 13.2, 95%CI 9.52 to 18.29, p<0.001). The subgroup analysis showed a rise in the prevalence of T2DM with increasing duration of follow-up. The conversion to T2DM and prediabetes is very high among women with history of GDM in SA and SEA. This highlights the need for follow-up of GDM women for early identification of dysglycemia and to plan interventions to prevent/delay the progression to T2DM.

UI MeSH Term Description Entries
D011236 Prediabetic State The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2). Prediabetes,Prediabetic States,State, Prediabetic,States, Prediabetic
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000095224 Southeast Asian People People native to or inhabitants of SOUTHEASTERN ASIA including BORNEO; BRUNEI; CAMBODIA; INDONESIA; LAOS; MALAYSIA; the MEKONG VALLEY; MYANMAR (formerly Burma), the PHILIPPINES; SINGAPORE; THAILAND; and VIETNAM. It includes people native or inhabitants of the MEKONG VALLEY. Southeast Asians,Southeastern Asian People,Southeastern Asians,Burmese,Cambodians,Thai,Vietnamese,Asian People, Southeast,Asian, Southeast,Asian, Southeastern,People, Southeast Asian,People, Southeastern Asian,Southeast Asian,Southeast Asian Peoples,Southeastern Asian,Southeastern Asian Peoples
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016640 Diabetes, Gestational Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA. Diabetes Mellitus, Gestational,Diabetes, Pregnancy-Induced,Gestational Diabetes,Diabetes, Pregnancy Induced,Gestational Diabetes Mellitus,Pregnancy-Induced Diabetes

Related Publications

Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
January 2021, Indian journal of endocrinology and metabolism,
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
May 2009, Lancet (London, England),
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
May 2020, BMJ (Clinical research ed.),
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
July 2021, The Indian journal of medical research,
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
January 2020, Journal of diabetes research,
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
January 2022, PloS one,
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
July 2017, Diabetes/metabolism research and reviews,
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
July 2008, Diabetes research and clinical practice,
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
April 2010, BMJ (Clinical research ed.),
Chockalingam Shivashri, and Wesley Hannah, and Mohan Deepa, and Yonas Ghebremichael-Weldeselassie, and Ranjit Mohan Anjana, and Ram Uma, and Viswanathan Mohan, and Ponnusamy Saravanan
June 2022, Journal of Nepal Health Research Council,
Copied contents to your clipboard!